Pharma News

Keep updating your pharma knowledge
28 Mar 2016

Zydus buys gastro therapy brand, Actibile from Albert David

Cadila Healthcare Limited has entered into a definitive agreement to acquire ‘Actibile’ from Albert David Limited (ADL).  The brand falls in the gastroenterology segment and is used for dissolving gall bladder stones. The deal will be financed through internal accruals
The gastrointestinal segment has been one of our core focus segment of Zydus. This acquisition will strengthen Zydus Gastro portfolio of brands and leverage our equity in gastro segment.
Actibile contains Ursodeoxycholic Acid

Ursodiol, also known as ursodeoxycholic acid and the abbreviation UDCA, is one of the secondary bile acids, which are metabolic byproducts of intestinal bacteria.

Leave a Reply

The reCAPTCHA verification period has expired. Please reload the page.

Upskill Your Pharma Knowledge

Explore Next Gen Learning

Case Studies & Caselets | Simulation Based Learning | E-Lectures | Online Self Competency Assessments

Thank You for Subscription!